Xanthine oxidoreductase-IN-3
Xanthine oxidoreductase-IN-3 is an orally active xanthine oxidoreductase (XOR) inhibitor, with an IC50 of 26.3 nM. Xanthine oxidoreductase-IN-3 can be used for the research of acute hyperuricemia[1].
Product Specifications
CAS Number
651769-78-7
UNSPSC
12352005
Hazard Statement
H228-H315-H319
Target
Xanthine Oxidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/xanthine-oxidoreductase-in-3.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=C(C=C1)C2=NN=NN2)NC3=CC=C(C=C3)Cl
Molecular Formula
C14H10ClN5O
Molecular Weight
299.72
Precautions
P210-P240-P241-P264-P280-P302+P352-P305+P351+P338-P362+P364-P370+P378
References & Citations
[1]Peng W, et, al. Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitors. Eur J Med Chem. 2022 Nov 28;246:114947.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog